Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 78 articles:
HTML format
Text format



Single Articles


    February 2018
  1. XING L, Xu W, Qu Y, Zhao M, et al
    miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
    Int J Hematol. 2018 Feb 27. pii: 10.1007/s12185-018-2429.
    PubMed     Text format     Abstract available


  2. SONODA M, Ishimura M, Ichimiya Y, Terashi E, et al
    Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.
    Int J Hematol. 2018 Feb 23. pii: 10.1007/s12185-018-2424.
    PubMed     Text format     Abstract available


  3. RAB MAE, Meerveld-Eggink A, van Velzen-Blad H, van Loon D, et al
    Persistent changes in circulating white blood cell populations after splenectomy.
    Int J Hematol. 2018;107:157-165.
    PubMed     Text format     Abstract available


    January 2018
  4. IKUTA K, Shimura A, Terauchi M, Yoshii K, et al
    Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with iron-deficiency anemia.
    Int J Hematol. 2018 Jan 22. pii: 10.1007/s12185-018-2400.
    PubMed     Text format     Abstract available


  5. GIRELLI D, Ugolini S, Busti F, Marchi G, et al
    Modern iron replacement therapy: clinical and pathophysiological insights.
    Int J Hematol. 2018;107:16-30.
    PubMed     Text format     Abstract available


    December 2017
  6. CHAROENKWAN P, Sirichotiyakul S, Phusua A, Suanta S, et al
    High-resolution melting analysis for prenatal diagnosis of beta-thalassemia in northern Thailand.
    Int J Hematol. 2017;106:757-764.
    PubMed     Text format     Abstract available


  7. ALGIRAIGRI AH, Kassam A
    Hydroxyurea for hemoglobin E/beta-thalassemia: a systematic review and meta-analysis.
    Int J Hematol. 2017;106:748-756.
    PubMed     Text format     Abstract available


    November 2017
  8. FURUYAMA K, Kaneko K
    Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.
    Int J Hematol. 2017 Nov 14. doi: 10.1007/s12185-017-2368.
    PubMed     Text format     Abstract available


  9. SRINOUN K, Nopparatana C, Wongchanchailert M, Fucharoen S, et al
    MiR-155 enhances phagocytic activity of beta-thalassemia/HbE monocytes via targeting of BACH1.
    Int J Hematol. 2017;106:638-647.
    PubMed     Text format     Abstract available


  10. KADDAH NA, Saied DA, Alwakeel HA, Hashem RH, et al
    Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.
    Int J Hematol. 2017;106:648-654.
    PubMed     Text format     Abstract available


  11. OHKAWARA H, Furukawa M, Ikeda K, Shichishima-Nakamura A, et al
    Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-beta in the bone marrow: a case report.
    Int J Hematol. 2017;106:718-724.
    PubMed     Text format     Abstract available


    October 2017
  12. IMATAKI O, Uchida S, Yokokura S, Uemura M, et al
    Anemia and hypogammaglobulinemia caused by Menetrier's disease.
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2349.
    PubMed     Text format    


    September 2017
  13. CUI Q, Sha P, Chen H, Shen H, et al
    Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Int J Hematol. 2017 Sep 12. doi: 10.1007/s12185-017-2321.
    PubMed     Text format     Abstract available


  14. SATITTHUMMANID S, Uaprasert N, Songmuang SB, Rojnuckarin P, et al
    Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in beta-thalassemia/HbE patients.
    Int J Hematol. 2017;106:366-374.
    PubMed     Text format     Abstract available


    August 2017
  15. XU X, Li L, Xia W, Ding H, et al
    Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody.
    Int J Hematol. 2017 Aug 16. doi: 10.1007/s12185-017-2310.
    PubMed     Text format     Abstract available


  16. UPANAN S, McKie AT, Latunde-Dada GO, Roytrakul S, et al
    Hepcidin suppression in beta-thalassemia is associated with the down-regulation of atonal homolog 8.
    Int J Hematol. 2017;106:196-205.
    PubMed     Text format     Abstract available


    July 2017
  17. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Text format     Abstract available


  18. TOKI Y, Ikuta K, Kawahara Y, Niizeki N, et al
    Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency.
    Int J Hematol. 2017;106:116-125.
    PubMed     Text format     Abstract available


    June 2017
  19. CHOI Y, Jo JC, Jeon HJ, Kim DW, et al
    Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.
    Int J Hematol. 2017 Jun 29. doi: 10.1007/s12185-017-2280.
    PubMed     Text format     Abstract available


  20. CHEUNG RS, Taniguchi T
    Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2283.
    PubMed     Text format     Abstract available


  21. LIU C, Zheng M, Zhang T, Fu R, et al
    TRAIL in CD8+ T cells from patients with severe aplastic anemia.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2279.
    PubMed     Text format     Abstract available


  22. ZHAO P, Gao Q, He Q, Tan J, et al
    Prevalence and clinical outcomes of hepatitis B virus infection in patients with aplastic anemia.
    Int J Hematol. 2017 Jun 13. doi: 10.1007/s12185-017-2276.
    PubMed     Text format     Abstract available


    May 2017
  23. URESHINO H, Kizuka H, Kusaba K, Sano H, et al
    5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Int J Hematol. 2017;105:692-696.
    PubMed     Text format     Abstract available


    April 2017
  24. ABAZA Y, Yin CC, Bueso-Ramos CE, Wang SA, et al
    Primary autoimmune myelofibrosis: a case report and review of the literature.
    Int J Hematol. 2017;105:536-539.
    PubMed     Text format     Abstract available


    March 2017
  25. WU L, Mo W, Zhang Y, Zhou M, et al
    Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2217.
    PubMed     Text format     Abstract available


  26. IKI S, Ohgi K, Suzuki K
    Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2017;105:231-232.
    PubMed     Text format    


  27. ZAHRAN AM, Saad K, Elsayh KI, Alblihed MA, et al
    Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with beta-thalassemia major.
    Int J Hematol. 2017;105:265-271.
    PubMed     Text format     Abstract available


  28. KOMATSU N, Kirito K, Shimoda K, Ishikawa T, et al
    Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
    Int J Hematol. 2017;105:309-317.
    PubMed     Text format     Abstract available


    February 2017
  29. WU L, Xu W, Xu L, Kong Q, et al
    Mitophagy is increased during erythroid differentiation in beta-thalassemia.
    Int J Hematol. 2017;105:162-173.
    PubMed     Text format     Abstract available


    January 2017
  30. HAYAKAWA J, Kanda J, Akahoshi Y, Harada N, et al
    Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Int J Hematol. 2017 Jan 11. doi: 10.1007/s12185-017-2179.
    PubMed     Text format     Abstract available


  31. IKEBE T, Takata H, Sasaki H, Miyazaki Y, et al
    Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
    Int J Hematol. 2017 Jan 4. doi: 10.1007/s12185-016-2177.
    PubMed     Text format    


    December 2016
  32. SEKIGUCHI N, Nishina S, Kawakami T, Sakai H, et al
    Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
    Int J Hematol. 2016 Dec 27. doi: 10.1007/s12185-016-2170.
    PubMed     Text format     Abstract available


    November 2016
  33. ICHIMURA T, Yoshida K, Okuno Y, Yujiri T, et al
    Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  34. NINOMIYA H, Obara N, Chiba S, Usuki K, et al
    Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2016;104:548-558.
    PubMed     Text format     Abstract available


    October 2016
  35. GUO Z, Gao HY, Zhang TY, Liu XD, et al
    Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  36. QI W, Yan L, Liu C, Fu R, et al
    Abnormal histone acetylation of CD8+ T cells in patients with severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  37. NAKAO S
    Diagnostic problems in acquired bone marrow failure syndromes.
    Int J Hematol. 2016;104:151-2.
    PubMed     Text format    


  38. INOUE S, Kodjebacheva G, Scherrer T, Rice G, et al
    Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.
    Int J Hematol. 2016;104:200-7.
    PubMed     Text format     Abstract available


  39. FALCHI L, Grillo LM, Diuguid-Gerber JL, Eisenberger AB, et al
    Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy.
    Int J Hematol. 2016;104:147-8.
    PubMed     Text format    


  40. MIYATA T, Uchida Y, Yoshida Y, Kato H, et al
    No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.
    Int J Hematol. 2016;104:223-7.
    PubMed     Text format     Abstract available


  41. MARSH JC, Mufti GJ
    Clinical significance of acquired somatic mutations in aplastic anaemia.
    Int J Hematol. 2016;104:159-67.
    PubMed     Text format     Abstract available


    July 2016
  42. LI Y, He H, Yang L, Li X, et al
    Therapeutic effect of Colla corii asini on improving anemia and hemoglobin compositions in pregnant women with thalassemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  43. CHUNCHARUNEE S, Wong R, Rojnuckarin P, Chang CS, et al
    Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  44. FU R, Yan S, Wang X, Wang G, et al
    A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  45. TAKAHASHI N, Kameoka J, Takahashi N, Tamai Y, et al
    Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  46. HASHIMOTO K, Harada M, Kamijo Y
    Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  47. SUZUKI T, Kobayashi H, Kawasaki Y, Okazuka K, et al
    Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  48. WAN Y, Chen X, An W, Ruan M, et al
    Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  49. BACIGALUPO A, Giammarco S, Sica S
    Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  50. SIWAPONANAN P, Fucharoen S, Sirankapracha P, Winichagoon P, et al
    Elevated levels of miR-210 correlate with anemia in beta-thalassemia/HbE patients.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  51. YU F, Du Y, Han B
    A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.
    Int J Hematol. 2016;103:649-54.
    PubMed     Text format     Abstract available


  52. TANTIWORAWIT A, Charoenkwan P, Hantrakool S, Choeyprasert W, et al
    Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Int J Hematol. 2016;103:643-8.
    PubMed     Text format     Abstract available


  53. PIGATTO PD, Ronchi A, Guzzi G
    Iron overload, G6PD deficiency, and lead levels on blood smears.
    Int J Hematol. 2016;103:724.
    PubMed     Text format    


  54. MIYASAKA N, Miura O, Kawaguchi T, Arima N, et al
    Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
    Int J Hematol. 2016;103:703-12.
    PubMed     Text format     Abstract available


    May 2016
  55. DIAMANTIDIS MD, Neokleous N, Agapidou A, Vetsiou E, et al
    Iron chelation therapy of transfusion-dependent beta-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Int J Hematol. 2016;103:537-44.
    PubMed     Text format     Abstract available


    April 2016
  56. SUZUKI K, Muramatsu H, Okuno Y, Narita A, et al
    Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  57. NARITA A, Kojima S
    Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  58. AIZAWA K, Kawasaki R, Tashiro Y, Hirata M, et al
    Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  59. HASEGAWA D
    The current perspective of low-grade myelodysplastic syndrome in children.
    Int J Hematol. 2016;103:360-4.
    PubMed     Text format     Abstract available


  60. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed     Text format    


  61. DALLE JH, Peffault de Latour R
    Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2016;103:373-9.
    PubMed     Text format     Abstract available


    March 2016
  62. IMASHUKU S, Muramatsu H, Sugihara T, Okuno Y, et al
    PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  63. ZHU H, Xu W, Liu H, Wang H, et al
    Expression of activated molecules on CD5B lymphocytes in autoimmune hemolytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  64. HATZIMICHAEL E, Briasoulis E
    Megaloblastic anemia presenting with skin hyperpigmentation.
    Int J Hematol. 2016.
    PubMed     Text format    


  65. FAN X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, et al
    Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
    Int J Hematol. 2016;103:283-91.
    PubMed     Text format     Abstract available


    February 2016
  66. MORI T, Koh H, Onishi Y, Kako S, et al
    Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  67. KOOK H, Chung NG, Kang HJ, Im HJ, et al
    Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  68. KATSURADA T, Kawabata H, Kawabata D, Kawahara M, et al
    A Japanese family with X-linked sideroblastic anemia affecting females and manifesting as macrocytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  69. ADDO L, Ikuta K, Tanaka H, Toki Y, et al
    The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).
    Int J Hematol. 2016;103:34-43.
    PubMed     Text format     Abstract available


    November 2015
  70. IKEDA F, Toki T, Kanezaki R, Terui K, et al
    ALDH2 polymorphism in patients with Diamond-Blackfan anemia in Japan.
    Int J Hematol. 2015.
    PubMed     Text format    


    October 2015
  71. WU L, Mo W, Zhang Y, Deng H, et al
    Impairment of hematopoietic stem cell niches in patients with aplastic anemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  72. XU ZZ, Zhao BB, Xiong H, Wei BW, et al
    Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  73. ONAY H, Aykut A, Karaca E, Durmaz A, et al
    Molecular spectrum of alpha-globin gene mutations in the Aegean region of Turkey: first observation of three alpha-globin gene mutations in the Turkish population.
    Int J Hematol. 2015;102:1-6.
    PubMed     Text format     Abstract available


    June 2015
  74. WANG M, Li X, Shi J, Shao Y, et al
    Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  75. YIGIT N, Covey S, Tam W
    Massive splenic hamartoma with bizarre stromal cells.
    Int J Hematol. 2015;101:315-6.
    PubMed     Text format    


  76. SAKURAGI M, Hayashi S, Maruyama M, Kabutomori O, et al
    Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders.
    Int J Hematol. 2015;101:369-75.
    PubMed     Text format     Abstract available


    February 2015
  77. VANDER MEEREN S, Van Damme A, Jochmans K
    Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
    Int J Hematol. 2015;101:112-3.
    PubMed     Text format    


  78. UNAL S, Ozdemir O, Ozcimen AA, Oztas Y, et al
    Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.
    Int J Hematol. 2015;101:114-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: